Catalyst
Slingshot members are tracking this event:
Data from VX-661 in combination with ivacaftor in approximately 500 people with CF who have two copies of the F508del mutatioion are expected in the first half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VRTX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 28, 2017
Occurred Source:
http://investors.vrtx.com/releasedetail.cfm?ReleaseID=1019156
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Vx-661, Ivacaftor, Cf, Cystic Fibrosis, F508del Mutation
